LITAF is a potential tumor suppressor in pancreatic cancer.

about

Current Challenges and Opportunities in Treating Glioblastoma.

P2860

Q52579808-65AEC1C7-03F3-43DB-93E5-CB5C5172736C

P2860

LITAF is a potential tumor suppressor in pancreatic cancer.

Item

http://www.wikidata.org/entity/Q49725736

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

LITAF is a potential tumor suppressor in pancreatic cancer.

@en

LITAF is a potential tumor suppressor in pancreatic cancer.

@nl

type

Item

label

LITAF is a potential tumor suppressor in pancreatic cancer.

@en

LITAF is a potential tumor suppressor in pancreatic cancer.

@nl

prefLabel

LITAF is a potential tumor suppressor in pancreatic cancer.

@en

LITAF is a potential tumor suppressor in pancreatic cancer.

@nl

P1476

LITAF is a potential tumor suppressor in pancreatic cancer.

@en

P2093

Caide Lu

http://www.w3.org/2001/XMLSchema#string

Guoping Ren

http://www.w3.org/2001/XMLSchema#string

Guoping Zhong

http://www.w3.org/2001/XMLSchema#string

Hongyang Pan

http://www.w3.org/2001/XMLSchema#string

Jing Huang

http://www.w3.org/2001/XMLSchema#string

Lizhen Lei

http://www.w3.org/2001/XMLSchema#string

Qingmeng Liu

http://www.w3.org/2001/XMLSchema#string

Ren Zhou

http://www.w3.org/2001/XMLSchema#string

Xi Yu

http://www.w3.org/2001/XMLSchema#string

Xiaowen Feng

http://www.w3.org/2001/XMLSchema#string

P2860

LPS induces the interaction of a transcription factor, LPS-induced TNF-alpha factor, and STAT6(B) with effects on multiple cytokines

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression

Pancreatic cancer treatment and research: an international expert panel discussion.

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Cancer statistics, 2012

PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease

Early detection of pancreatic cancer: why, who, and how to screen

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

P304

3131-3142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23220

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423035

http://www.w3.org/2001/XMLSchema#string

P932

5790452

http://www.w3.org/2001/XMLSchema#string

LITAF is a potential tumor suppressor in pancreatic cancer.

about

P2860

P2860

LITAF is a potential tumor suppressor in pancreatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932